Shravanthi R. Gandra, Ph.D.

Affiliations: 
2005 University Of Louisiana at Monroe 
Area:
Pharmacy, Health Care Management
Google:
"Shravanthi Gandra"

Parents

Sign in to add mentor
Lesa Lawrence grad student 2005 University Of Louisiana at Monroe
 (Development of a risk stratification tool for predicting hospitalization from macrovascular complications among diabetic patients in a managed care environment.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blieden M, Gandra SR, Cheng LI, et al. (2017) Differences in utility elicitation methods in cardiovascular disease: a systematic review. Journal of Medical Economics. 1-23
Rosenson RS, Gandra SR, McKendrick J, et al. (2017) Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries. Cardiovascular Drugs and Therapy
Villa G, Lothgren M, Kutikova L, et al. (2017) Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain. Clinical Therapeutics
Punekar RS, Fox KM, Paoli CJ, et al. (2017) Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study. Current Medical Research and Opinion. 1-8
Deshpande S, Quek RG, Forbes CA, et al. (2017) A systematic review to assess the adherence and persistence with statins. Current Medical Research and Opinion. 1-23
Burke JP, Simpson RJ, Paoli CJ, et al. (2016) Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy. Journal of Clinical Lipidology. 10: 1470-1480.e3
Gordois AL, Toth PP, Quek RG, et al. (2016) Productivity losses associated with cardiovascular disease: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research
Wei CY, Quek RG, Villa G, et al. (2016) A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. Pharmacoeconomics
Nicholson G, Gandra SR, Halbert RJ, et al. (2016) Patient-level costs of major cardiovascular conditions: a review of the international literature. Clinicoeconomics and Outcomes Research : Ceor. 8: 495-506
Forbes CA, Quek RG, Deshpande S, et al. (2016) The relationship between Lp(a) and CVD outcomes: a systematic review. Lipids in Health and Disease. 15: 95
See more...